These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 19127123

  • 21. Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the future.
    Fiorucci S.
    Gastroenterol Clin North Am; 2009 Jun; 38(2):315-32. PubMed ID: 19446261
    [Abstract] [Full Text] [Related]

  • 22. Non-steroidal antiinflammatory drugs. A review.
    Winzeler S, Rosenstein BD.
    AAOHN J; 1998 May; 46(5):253-9; quiz 260-1. PubMed ID: 9652239
    [Abstract] [Full Text] [Related]

  • 23. Balancing the gastrointestinal benefits and risks of nonselective NSAIDs.
    Peura DA, Goldkind L.
    Arthritis Res Ther; 2005 May; 7 Suppl 4(Suppl 4):S7-13. PubMed ID: 16168079
    [Abstract] [Full Text] [Related]

  • 24. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
    Vakil N.
    Rev Gastroenterol Disord; 2006 May; 6(4):221-6. PubMed ID: 17224894
    [Abstract] [Full Text] [Related]

  • 25. Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Jones R, Rubin G, Berenbaum F, Scheiman J.
    Am J Med; 2008 Jun; 121(6):464-74. PubMed ID: 18501223
    [Abstract] [Full Text] [Related]

  • 26. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
    Dajani EZ, Islam K.
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633
    [Abstract] [Full Text] [Related]

  • 27. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Fiorucci S, Santucci L, Distrutti E.
    Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
    [Abstract] [Full Text] [Related]

  • 28. Update on the role of nonsteroidal anti-inflammatory drugs and coxibs in the management of acute pain.
    Reuben SS.
    Curr Opin Anaesthesiol; 2007 Oct; 20(5):440-50. PubMed ID: 17873597
    [Abstract] [Full Text] [Related]

  • 29. [Effects of nonsteroidal anti-inflammatory agents on the gastrointestinal tract].
    Bures J, Rejchrt S, Kopácová M, Siroký M.
    Cas Lek Cesk; 2002 Oct 25; 141(21):673-9. PubMed ID: 12564374
    [Abstract] [Full Text] [Related]

  • 30. Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks.
    Chan FK.
    Nat Clin Pract Gastroenterol Hepatol; 2006 Oct 25; 3(10):563-73. PubMed ID: 17008926
    [Abstract] [Full Text] [Related]

  • 31. Cyclooxygenase-2 inhibitors and other nonsteroidal anti-inflammatory drugs in the treatment of musculoskeletal conditions.
    Austin MS, Abdul-Hadi O, Parvizi J, Viscusi ER, Einhorn T.
    Instr Course Lect; 2009 Oct 25; 58():759-68. PubMed ID: 19385584
    [Abstract] [Full Text] [Related]

  • 32. Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal.
    Davies NM, Reynolds JK, Undeberg MR, Gates BJ, Ohgami Y, Vega-Villa KR.
    Expert Rev Neurother; 2006 Nov 25; 6(11):1643-55. PubMed ID: 17144779
    [Abstract] [Full Text] [Related]

  • 33. Balancing risks and benefits of cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs.
    Scheiman JM.
    Gastroenterol Clin North Am; 2009 Jun 25; 38(2):305-14. PubMed ID: 19446260
    [Abstract] [Full Text] [Related]

  • 34. Selective cyclooxygenase inhibition: its role in pain and anaesthesia.
    Langford RM, Mehta V.
    Biomed Pharmacother; 2006 Aug 25; 60(7):323-8. PubMed ID: 16837162
    [Abstract] [Full Text] [Related]

  • 35. Renal colic in adults: NSAIDs and morphine are effective for pain relief.
    Prescrire Int; 2009 Oct 25; 18(103):217-21. PubMed ID: 19882796
    [Abstract] [Full Text] [Related]

  • 36. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs].
    van den Bemt BJ, Benraad HB, Rasker JJ.
    Ned Tijdschr Geneeskd; 2007 May 12; 151(19):1062-7. PubMed ID: 17552414
    [Abstract] [Full Text] [Related]

  • 37. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.
    Hermann M, Ruschitzka F.
    Ann Med; 2007 May 12; 39(1):18-27. PubMed ID: 17364448
    [Abstract] [Full Text] [Related]

  • 38. Gastrointestinal tolerability of aspirin and the choice of over-the-counter analgesia for short-lasting acute pain.
    Steiner TJ, Voelker M.
    J Clin Pharm Ther; 2009 Apr 12; 34(2):177-86. PubMed ID: 19250138
    [Abstract] [Full Text] [Related]

  • 39. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.
    Farkouh ME, Greenberg BP.
    Am J Cardiol; 2009 May 01; 103(9):1227-37. PubMed ID: 19406264
    [Abstract] [Full Text] [Related]

  • 40. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.
    van der Linden MW, Gaugris S, Kuipers EJ, van Herk-Sukel MP, van den Bemt BJ, Sen SS, Herings RM.
    Pharmacoepidemiol Drug Saf; 2009 Oct 01; 18(10):880-90. PubMed ID: 19593747
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.